LB Pharmaceuticals Inc Common Stock (LBRX) vs Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

A side-by-side comparison of LB Pharmaceuticals Inc Common Stock and Lumexa Imaging Holdings, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
LB Pharmaceuticals Inc Common Stock logo
LBRX
LB Pharmaceuticals Inc Common Stock
$978M
$34.12HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Lumexa Imaging Holdings, Inc. Common Stock logo
LMRI
Lumexa Imaging Holdings, Inc. Common Stock
$1.02B
$10.65HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

Total return — LBRX vs LMRI

growth of $100 · dividends reinvested · last 1y
LBRX +71.1% (+71.1%/yr)LMRI -41.8% (-41.8%/yr)LBRX compounded faster over this window
50100150200250Start $1002026$171$58
LBRX LMRI

LBRX vs LMRI: by the numbers

  • •LMRI is the larger company ($1.02B vs $978M market cap).
  • •Both run net losses; LBRX's is the smaller (0.00% vs -2.66% net margin).

Metrics side by side

Valuation

MetricLBRXLMRI
Forward P/EN/A16.58
P/S ratioN/A0.98
P/B ratio2.941.66
EV / EBITDAN/A27.98
FCF yieldN/A3.11%

Profitability

MetricLBRXLMRI
Gross margin0.00%11.80%
Operating margin0.00%1.38%
Net margin0.00%-2.66%
ROE-25.78%-4.51%
ROIC-28.14%0.86%

Go deeper

Full LBRX analysisFull LMRI analysisInteractive comparison tool

Dig into the metrics

LB Pharmaceuticals Inc Common Stock ROELumexa Imaging Holdings, Inc. Common Stock ROELB Pharmaceuticals Inc Common Stock operating marginLumexa Imaging Holdings, Inc. Common Stock operating marginLB Pharmaceuticals Inc Common Stock revenue growthLumexa Imaging Holdings, Inc. Common Stock revenue growthLB Pharmaceuticals Inc Common Stock free cash flowLumexa Imaging Holdings, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.